Scott A. Holmes, Chief Financial Officer at KERYX BIOPHARMACEUTICALS INC (KERX), bought 5,000 shares at $5.40 ($27K) on 2015-11-04, disclosed to the SEC on 2015-11-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.30 | 3,672 | $19K | 73.1% |
| 2 | $5.40 | 1,328 | $7K | 26.9% |
| Total | $5.33 avg | 5,000 | $27K | 100% |
| Filing → |
| KERX | SELL | 2018-08-16 | $4K | — | Filing → |
| KERX | SELL | 2018-07-31 | $9K | — | Filing → |
| KERX | SELL | 2018-05-16 | $7K | — | Filing → |